Literature DB >> 7694052

Enhancement and neutralization of feline infectious peritonitis virus infection in feline macrophages by neutralizing monoclonal antibodies recognizing different epitopes.

T Hohdatsu1, H Yamada, Y Ishizuka, H Koyama.   

Abstract

The interaction between the enhancing and neutralizing activities of three monoclonal antibodies (MAbs) (5-6-2, 6-4-2 and 7-4-1) to the spike protein of feline infectious peritonitis virus (FIPV) strain 79-1146 was determined using feline macrophages. At a high MAb concentration, all of the three MAbs completely inhibited the FIPV infection at 37 C. However, two of them (6-4-2 and 7-4-1) enhanced FIPV infection when either the MAb concentration or reaction temperature was lowered. These MAbs also exerted an immediate infectivity-enhancing activity for up to 10 min of reaction and by 20 min, neutralizing activities were observed. Only MAb 5-6-2 consistently showed neutralizing activity regardless of the reaction conditions. Competition with sera from cats experimentally infected with FIPV strain 79-1146 or feline enteric coronavirus strain 79-1683 showed that the two epitopes recognized by MAb 5-6-2 and MAb 6-4-2, respectively, are also recognized by the natural host.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694052      PMCID: PMC7168507          DOI: 10.1111/j.1348-0421.1993.tb03242.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


antibody‐dependent enahancement Crandell feline kidney enzyme‐linked immunosorbent assay feline whole fetus cells feline enteric coronavirus feline infectious peritonitis virus Hanks' balanced salt solution indirect fluorescent antibody assay monoclonal antibody monoclonal antibodies transmembrane protein neutralization test phosphate‐buffered saline solution respiratory syncytial virus peplomer spike protein 50% tissue culture infectious dose.
  22 in total

1.  Immunologic phenomena in the effusive form of feline infectious peritonitis.

Authors:  N C Petersen; J F Boyle
Journal:  Am J Vet Res       Date:  1980-06       Impact factor: 1.156

2.  Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies.

Authors:  S B Halstead; C N Venkateshan; M K Gentry; L K Larsen
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

3.  Antibody-enhanced dengue virus infection in primate leukocytes.

Authors:  S B Halstead; E J O'Rourke
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

4.  Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis.

Authors:  A C Chanas; E A Gould; J C Clegg; M G Varma
Journal:  J Gen Virol       Date:  1982-01       Impact factor: 3.891

Review 5.  Pathogenesis of dengue: challenges to molecular biology.

Authors:  S B Halstead
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

6.  Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines.

Authors:  J S Peiris; J S Porterfield
Journal:  Nature       Date:  1979-11-29       Impact factor: 49.962

7.  Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.

Authors:  A Takeda; C U Tuazon; F A Ennis
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

8.  Characterization of monoclonal antibodies against feline infectious peritonitis virus type II and antigenic relationship between feline, porcine, and canine coronaviruses.

Authors:  T Hohdatsu; S Okada; H Koyama
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.

Authors:  S B Halstead; E J O'Rourke
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

10.  Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever.

Authors:  R C Weiss; F W Scott
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1981       Impact factor: 2.268

View more
  15 in total

1.  Laboratory profiles in cats with different pathological and immunohistochemical findings due to feline infectious peritonitis (FIP).

Authors:  S Paltrinieri; V Grieco; S Comazzi; M Cammarata Parodi
Journal:  J Feline Med Surg       Date:  2001-09       Impact factor: 2.015

Review 2.  The landscape of bispecific T cell engager in cancer treatment.

Authors:  Shujie Zhou; Mingguo Liu; Fei Ren; Xiangjiao Meng; Jinming Yu
Journal:  Biomark Res       Date:  2021-05-26

Review 3.  Feline coronavirus in multicat environments.

Authors:  Yvonne Drechsler; Ana Alcaraz; Frank J Bossong; Ellen W Collisson; Pedro Paulo V P Diniz
Journal:  Vet Clin North Am Small Anim Pract       Date:  2011-11       Impact factor: 2.093

4.  Mutation of neutralizing/antibody-dependent enhancing epitope on spike protein and 7b gene of feline infectious peritonitis virus: influences of viral replication in monocytes/macrophages and virulence in cats.

Authors:  Tomomi Takano; Yoshika Tomiyama; Yasuichiroh Katoh; Michiyo Nakamura; Ryoichi Satoh; Tsutomu Hohdatsu
Journal:  Virus Res       Date:  2011-01-04       Impact factor: 3.303

5.  Characterization of T helper (Th)1- and Th2-type immune responses caused by baculovirus-expressed protein derived from the S2 domain of feline infectious peritonitis virus, and exploration of the Th1 and Th2 epitopes in a mouse model.

Authors:  Ryoichi Satoh; Hiroshige Kobayashi; Tomomi Takano; Kenji Motokawa; Hajime Kusuhara; Tsutomu Hohdatsu
Journal:  Microbiol Immunol       Date:  2010-12       Impact factor: 1.955

6.  TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages.

Authors:  Tomomi Takano; Tsutomu Hohdatsu; Ayako Toda; Maki Tanabe; Hiroyuki Koyama
Journal:  Virology       Date:  2007-03-23       Impact factor: 3.616

7.  Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in the spike 2 domain and the nucleocapsid protein of feline infectious peritonitis virus.

Authors:  Ryoichi Satoh; Tomoko Furukawa; Masako Kotake; Tomomi Takano; Kenji Motokawa; Tsuyoshi Gemma; Rie Watanabe; Setsuo Arai; Tsutomu Hohdatsu
Journal:  Vaccine       Date:  2011-01-07       Impact factor: 3.641

8.  Animal models and vaccines for SARS-CoV infection.

Authors:  Anjeanette Roberts; Elaine W Lamirande; Leatrice Vogel; Jadon P Jackson; Christopher D Paddock; Jeannette Guarner; Sherif R Zaki; Timothy Sheahan; Ralph Baric; Kanta Subbarao
Journal:  Virus Res       Date:  2007-05-11       Impact factor: 3.303

9.  Shifts in circulating lymphocyte subsets in cats with feline infectious peritonitis (FIP): pathogenic role and diagnostic relevance.

Authors:  Saverio Paltrinieri; Wilma Ponti; Stefano Comazzi; Alessia Giordano; Giorgio Poli
Journal:  Vet Immunol Immunopathol       Date:  2003-12-15       Impact factor: 2.046

10.  Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo.

Authors:  Tomomi Takano; Yasuichiroh Katoh; Tomoyoshi Doki; Tsutomu Hohdatsu
Journal:  Antiviral Res       Date:  2013-05-03       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.